• LAST PRICE
    41.6100
  • TODAY'S CHANGE (%)
    Trending Up0.1400 (0.3376%)
  • Bid / Lots
    41.6000/ 4
  • Ask / Lots
    41.6100/ 1
  • Open / Previous Close
    41.6400 / 41.4700
  • Day Range
    Low 41.4800
    High 41.6800
  • 52 Week Range
    Low 19.5900
    High 43.5898
  • Volume
    146,699
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 41.47
TimeVolumeCERE
09:32 ET768341.5502
09:34 ET1484641.515
09:36 ET134541.5
09:38 ET40041.5
09:39 ET30041.545
09:41 ET30041.625
09:43 ET150041.65
09:45 ET28641.66
09:48 ET119841.65
09:50 ET40041.61
09:52 ET90041.63
09:54 ET60041.63
09:56 ET198741.585
09:57 ET61541.605
09:59 ET55041.6
10:01 ET137341.57
10:03 ET53741.559
10:06 ET331341.55
10:08 ET90041.535
10:10 ET379041.545
10:12 ET497541.555
10:14 ET63841.54
10:15 ET20441.53
10:17 ET60041.535
10:19 ET70041.55
10:21 ET80941.54
10:24 ET49241.545
10:26 ET32441.55
10:28 ET60041.545
10:30 ET150441.55
10:32 ET120041.555
10:35 ET50041.555
10:37 ET121541.55
10:39 ET100041.59
10:42 ET160041.555
10:44 ET125241.56
10:46 ET70041.57
10:48 ET111341.575
10:50 ET30041.6
10:51 ET170041.56
10:53 ET132741.56
10:55 ET100041.545
10:57 ET70041.545
11:00 ET20041.55
11:02 ET90041.545
11:04 ET50041.56
11:06 ET83141.578
11:08 ET60041.58
11:09 ET880141.595
11:11 ET60041.6
11:13 ET797241.6
11:15 ET686541.5925
11:18 ET869741.6
11:20 ET534741.585
11:22 ET50041.6
11:24 ET20041.61
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCERE
Cerevel Therapeutics Holdings Inc
7.6B
-15.3x
---
United StatesPCVX
Vaxcyte Inc
7.8B
-17.1x
---
United StatesCYTK
Cytokinetics Inc
6.1B
-9.8x
---
United StatesRVMD
Revolution Medicines Inc
6.1B
-9.9x
---
United StatesMDGL
Madrigal Pharmaceuticals Inc
5.9B
-12.0x
---
United StatesVKTX
Viking Therapeutics Inc
5.7B
-55.8x
---
As of 2024-06-18

Company Information

Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It focuses on transform the lives of patients through the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer’s disease psychosis, epilepsy, panic disorder and Parkinson’s disease. Its pipeline candidates include Emraclidine, Darigabat, Tavapadon and CVL-871. Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype (M4). Darigabat is a PAM that selectively targets the alpha 2/3/5 subunits of the GABAA receptor. Tavapadon is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of Parkinson’s disease.

Contact Information

Headquarters
222 Jacobs Street, Suite 200CAMBRIDGE, MA, United States 02141
Phone
212-284-2300
Fax
302-636-5454

Executives

Chairperson of the Board of Directors
N. Anthony Coles
President, Chief Executive Officer, Member of the Board
Ronald Renaud
Chief Financial Officer
Susan Altschuller
Chief Human Resources Officer
Kenneth Dipietro
Senior Vice President - Finance, Chief Accounting Officer
Mark Bodenrader

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$7.6B
Revenue (TTM)
$0.00
Shares Outstanding
182.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.41
EPS
$-2.72
Book Value
$3.71
P/E Ratio
-15.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.